immunisbiomedical.com
Get leads like Immunisbiomedical — and thousands more
Build targeted lists by tech stack, traffic, and more
Immunis: The Secretome Bet on Reversing Aging
A private biotech with $37M funding, 21 employees, and a radical approach to immune dysfunction.
In the crowded longevity market, Immunis isn't chasing simple hormones or senolytics. They are betting the house on the 'secretome'—a complex cocktail of bioactive molecules secreted by stem cells—to treat age-related immune dysfunction. It's a high-risk, high-reward play in a market desperate for breakthroughs.
"Immunis isn't isolating a single molecule; they are attempting to bottle the biological conversation of youth."
The Technology: Beyond Stem Cells
Most stem cell therapies focus on the cells themselves replacing damaged tissue. Immunis pivots to the 'secretome'—the paracrine signaling factors these cells release. By harvesting this secretome from adipose-derived stem cells, they aim to treat age-related immune dysfunction without the risks of cell transplantation. It’s a move from structural repair to functional rejuvenation.
The SEO Paradox
Here is the data anomaly: For a biotech company focused on secretomes, their top organic keywords reveal a different strategy entirely. They rank for 'Peter Diamandis' (11,540 volume), 'Moonshots Podcast', and 'sarcopenic'. This suggests a content strategy targeting the longevity-lifestyle audience rather than pure clinical search terms, likely capitalizing on the founder's network (likely connected to the XPRIZE/longevity ecosystem) rather than direct disease queries.
The team is small—just 21 employees—which is remarkably efficient for a company generating $3.3M in revenue and holding $37M in funding. This capital efficiency suggests they are heavily outsourcing manufacturing or clinical trials while keeping core R&D in-house. The domain traffic is low (2,901 visits), but for a pre-revenue therapeutic biotech, direct traffic (41%) is often a better signal of investor and partner interest than broad public reach.
- Therapeutic Focus: Age-related immune dysfunction (immunosenescence).
- Core Asset: The 'IMM-101' secretome platform (implied).
- Business Model: Likely B2B licensing or eventual clinical trial sales.
- Tech Stack: Surprisingly robust (Tailwind, WooCommerce) for a deep-tech firm, indicating a strong digital presence for fundraising.
The Verdict: A Quiet Giant in the Making?
With $37M in the bank and a focused leadership team, Immunis is playing the long game. Their low web footprint belies the serious capital backing their clinical ambitions. For investors, the key metric isn't web traffic—it's the clinical data from their secretome trials.
What tech stack does Immunisbiomedical use?
How much traffic does Immunisbiomedical get?
Traffic & Engagement
Traffic Sources
Where is Immunisbiomedical's audience located?
What keywords does Immunisbiomedical rank for?
5 keywordsHow is Immunisbiomedical's SEO?
Meta Tags
Therapeutics targeting age-related disease
Discover how Immunis, a private biotechnology company is developing new secretome products for the treatment of age-related immune dysfunction
Home
Immunis is a clinical-stage biotechnology company targeting age-driven diseases to promote a healthier lifespan.
Schema Types
What is Immunisbiomedical's revenue?
Who works at Immunisbiomedical?
Loading leads...
What do customers think of Immunisbiomedical?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Immunisbiomedical
What is Immunisbiomedical's Revenue?
What does Immunisbiomedical do?
How fast is Immunisbiomedical growing?
What technologies does Immunisbiomedical use?
Who are Immunisbiomedical's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Immunisbiomedical?
Contact Information
Export immunisbiomedical.com Data
Download the complete tech stack, analytics, leads, and company data for immunisbiomedical.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About immunisbiomedical.com
Discover how Immunis, a private biotechnology company is developing new secretome products for the treatment of age-related immune dysfunction
Company Overview
Contact immunisbiomedical.com
Email Addresses
Phone Numbers
Technology Stack
immunisbiomedical.com uses 17 technologies across their website including Font Awesome, Google Fonts, reCAPTCHA, PHP, and more.
Fonts
Font Awesome, Google Fonts
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Scheduling
Cal.com
Customer Support
Zendesk
Traffic & Audience
immunisbiomedical.com receives approximately 2.9K monthly visitors and ranks #5,587,800 globally. The website has a bounce rate of 47% with visitors viewing an average of 1.8 pages per visit. Users spend an average of 2:48 on the site.
The majority of immunisbiomedical.com's traffic comes from undefined, .
Frequently Asked Questions
What is immunisbiomedical.com?
What technologies does immunisbiomedical.com use?
How do I contact immunisbiomedical.com?
How popular is immunisbiomedical.com?
Related Searches
This page provides publicly available information about immunisbiomedical.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit immunisbiomedical.com directly at https://immunisbiomedical.com.